Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


EMBL Conference: Genome Editing Using Zinc Finger Nucleases

14 Nov 2013 - 15 Nov 2013 - EMBL Heidelberg, Germany



Bookmark and Share


Zinc finger nucleases (ZFNs) enable manipulation of the genome with unprecedented ease and precision. ZFNs are a class of engineered DNA-binding proteins that facilitate targeted editing of the genome by creating double-strand breaks in DNA at user-specified locations. ZFNs have already been used to generate targeted genomic deletions of large segments of DNA in different cell types and organisms like mouse and human cells, plants, fruit flies, zebrafish, and rat. Recently, ZFNs have been used to disrupt or tag genes in human pluripotent stem cells, a system of tremendous interest for genome engineering that was lacking a reliable gene manipulation tool. Featuring keynote presentations, this conference will allow participants to discover the latest applications of transgenics and cell based models for the study of gene regulation and disease. Comprehensive lectures provide in-depth discussion on the fundamentals of ZFNs as well as innovative applications for targeted gene knockout, integration, and tagging. Geared towards scientists interested in learning about the technology, the conference provides researchers at all levels with a unique opportunity for networking with peers. Discussions will facilitate the exchange of ideas to shape the future directions of research in this key area.

Topics

  • Gene tagging
  • Genome editing in stem cells
  • Transgenic animal models
  • Gene knockout
  • Recent advances in ZFN technology



Further information
Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Smart Patch Releases Blood Thinners When Needed
Researchers have developed a smart patch that activelly monitors a patient's blood and releases blood thinning drugs when necessary.
First-Ever Capsule to Treat Hemophilia
In the near future, hemophiliacs could be able to treat their disease by simply swallowing a capsule.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
New Compound to Reduce Tumor Growth
Researchers at Stanford found that a new cell surface receptor they created is effective at inhibiting cancer growth in mice.
Long-Lasting Pill to Fight Malaria
An ultra-long acting pill has been developed to offer a new hope in eliminating malaria.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Synthetic Protein Captures DNA Events Leading to Cancer
A team of scientists have developed new technology allowing them to identify molecular intermediates that can drive genetic change.
Precision Medicine for Rheumatoid Arthritis
Researchers identify gene mechanism that increases rheumatoid arthritis risk in susceptable individuals.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!